BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8258715)

  • 41. Interferon gamma augments Lym-1-dependent, granulocyte-mediated tumor cell lysis.
    Vaickus L; Biddle W; Cemerlić D; Foon KA
    Blood; 1990 Jun; 75(12):2408-16. PubMed ID: 2140949
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The regulatory role of CD45 on rat NK cells in target cell lysis.
    Giezeman-Smits KM; Gorter A; van Vlierberghe RL; v Eendenburg JD; Eggermont AM; Fleuren GJ; Kuppen PJ
    J Immunol; 1999 Jul; 163(1):71-6. PubMed ID: 10384101
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of function-associated molecules in target cell lysis: analysis of rat adherent lymphokine-activated killer cells.
    Jaso-Friedmann L; Leary JH; Evans DL
    Nat Immun; 1993; 12(6):316-25. PubMed ID: 8268715
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CpG-A and B oligodeoxynucleotides enhance the efficacy of antibody therapy by activating different effector cell populations.
    van Ojik HH; Bevaart L; Dahle CE; Bakker A; Jansen MJ; van Vugt MJ; van de Winkel JG; Weiner GJ
    Cancer Res; 2003 Sep; 63(17):5595-600. PubMed ID: 14500400
    [TBL] [Abstract][Full Text] [Related]  

  • 45. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
    Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
    Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tandemly repeated Fc domain augments binding avidities of antibodies for Fcgamma receptors, resulting in enhanced antibody-dependent cellular cytotoxicity.
    Nagashima H; Tezuka T; Tsuchida W; Maeda H; Kohroki J; Masuho Y
    Mol Immunol; 2008 May; 45(10):2752-63. PubMed ID: 18353438
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Ch14.18-GM-CSF fusion protein is effective at mediating antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity in vitro.
    Batova A; Kamps A; Gillies SD; Reisfeld RA; Yu AL
    Clin Cancer Res; 1999 Dec; 5(12):4259-63. PubMed ID: 10632368
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transgenic expression of HLA-E single chain trimer protects porcine endothelial cells against human natural killer cell-mediated cytotoxicity.
    Lilienfeld BG; Crew MD; Forte P; Baumann BC; Seebach JD
    Xenotransplantation; 2007 Mar; 14(2):126-34. PubMed ID: 17381687
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An improved method to quantify human NK cell-mediated antibody-dependent cell-mediated cytotoxicity (ADCC) per IgG FcR-positive NK cell without purification of NK cells.
    Sung AP; Tang JJ; Guglielmo MJ; Redelman D; Smith-Gagen J; Bateman L; Hudig D
    J Immunol Methods; 2018 Jan; 452():63-72. PubMed ID: 29113954
    [TBL] [Abstract][Full Text] [Related]  

  • 50. lenalidomide enhances natural killer cell and monocyte-mediated antibody-dependent cellular cytotoxicity of rituximab-treated CD20+ tumor cells.
    Wu L; Adams M; Carter T; Chen R; Muller G; Stirling D; Schafer P; Bartlett JB
    Clin Cancer Res; 2008 Jul; 14(14):4650-7. PubMed ID: 18628480
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Granulocyte-colony stimulating factor enhances chimeric antibody Nd2 dependent cytotoxicity against pancreatic cancer mediated by polymorphonuclear neutrophils.
    Tamamori Y; Sawada T; Nishihara T; Yamashita Y; Ohira M; Ho JJ; Kim YS; Hirakawa-Y S Chung K
    Int J Oncol; 2002 Sep; 21(3):649-54. PubMed ID: 12168113
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neutrophils contribute to the biological antitumor activity of rituximab in a non-Hodgkin's lymphoma severe combined immunodeficiency mouse model.
    Hernandez-Ilizaliturri FJ; Jupudy V; Ostberg J; Oflazoglu E; Huberman A; Repasky E; Czuczman MS
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5866-73. PubMed ID: 14676108
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The role of apoptosis in antibody-dependent cell-mediated cytotoxicity against monolayers of human squamous cell carcinoma of the head and neck targets.
    Sung MW; Nagashima S; Johnson JT; Van Dongen GA; Whiteside TL
    Cell Immunol; 1996 Jul; 171(1):20-9. PubMed ID: 8660833
    [TBL] [Abstract][Full Text] [Related]  

  • 54. NK cells from mammary tumor bearing mice do not exert natural killer activity but function as antibody dependent cellular cytotoxicity effectors.
    Rivera LM; Lopez DM
    Anticancer Res; 1993; 13(1):177-84. PubMed ID: 8476211
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Self-reactive antibody expression by human carcinoma cells engineered with monoclonal antibody genes.
    Primus FJ; Finch MD; Masci AM; Schlom J; Kashmiri SV
    Cancer Res; 1993 Jul; 53(14):3355-61. PubMed ID: 8324746
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human NK cells can lyse porcine endothelial cells independent of their expression of Galalpha(1,3)-Gal and killing is enhanced by activation of either effector or target cells.
    Horvath-Arcidiacono JA; Porter CM; Bloom ET
    Xenotransplantation; 2006 Jul; 13(4):318-27. PubMed ID: 16768725
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synergistic inhibition of human cell-mediated cytotoxicity by complement component antisera indicates that target cell lysis may result from an enzymatic cascade involving granzymes and perforin.
    Brahmi Z; Csipo I; Bochan MR; Su B; Montel AH; Morse PA
    Nat Immun; 1995 Sep; 14(5-6):271-85. PubMed ID: 8933821
    [TBL] [Abstract][Full Text] [Related]  

  • 58. K-cell-mediated cytotoxicity induced with rat monoclonal antibodies. I. Antibodies of various isotypes differ in their ability to induce cytotoxicity mediated by rat and human effectors.
    Chassoux DM; Linares-Cruz LG; Bazin H; Stanislawski M
    Immunology; 1988 Dec; 65(4):623-8. PubMed ID: 3220507
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Spontaneous cell-mediated cytotoxicity of blood granulocytes and monocytes in vitro].
    Adomaĭtene D; Dedinene IaL; Vil'kiavichiute II
    Tsitologiia; 1980 Dec; 22(12):1442-6. PubMed ID: 7210182
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization of monoclonal antibodies against porcine pulmonary alveolar macrophages of gnotobiotic miniature swine.
    Hwang JH; Kim SE; Jung SH; Kim YK; Kim YB; Lee HT
    Biochem Biophys Res Commun; 2015 May; 461(2):427-34. PubMed ID: 25896759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.